Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Efficacy and Safety of Fractionated Stereotactic Radiosurgery for Large Brain Metastases

  • Jeong, Won Joo (Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Jae Hong (Department of Radiosurgery Center, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Eun Jung (Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Jeong Hoon (Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Chang Jin (Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Cho, Young Hyun (Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2015.03.27
  • Accepted : 2015.08.20
  • Published : 2015.10.28
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : To investigate the efficacy and safety of fractionated stereotactic radiosurgery for large brain metastases (BMs). Methods : Between June 2011 and December 2013, a total of 38 large BMs >3.0 cm in 37 patients were treated with fractionated Cyberknife radiosurgery. These patients comprised 16 men (43.2%) and 21 women, with a median age of 60 years (range, 38-75 years). BMs originated from the lung (n=19, 51.4%), the gastrointestinal tract (n=10, 27.0%), the breast (n=5, 13.5%), and other tissues (n=3, 8.1%). The median tumor volume was 17.6 cc (range, 9.4-49.6 cc). For Cyberknife treatment, a median peripheral dose of 35 Gy (range, 30-41 Gy) was delivered in 3 to 5 fractions. Results : With a median follow-up of 10 months (range, 1-37 months), the crude local tumor control (LTC) rate was 86.8% and the estimated LTC rates at 12 and 24 months were 87.0% and 65.2%, respectively. The median overall survival (OS) and progression-free survival (PFS) rates were 16 and 11 months, respectively. The estimated OS and PFS rates at 6, 12, and 18 months were 81.1% and 65.5%, 56.8% and 44.9%, and 40.7% and 25.7%, respectively. Patient performance status and preoperative focal neurologic deficits improved in 20 of 35 (57.1%) and 12 of 17 patients (70.6%), respectively. Radiation necrosis with a toxicity grade of 2 or 3 occurred in 6 lesions (15.8%). Conclusion : These results suggest a promising role of fractionated stereotactic radiosurgery in treating large BMs in terms of both efficacy and safety.

Keywords

References

  1. Aoyama H, Shirato H, Onimaru R, Kagei K, Ikeda J, Ishii N, et al. : Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys 56 : 793-800, 2003 https://doi.org/10.1016/S0360-3016(03)00014-2
  2. Bir SC, Ambekar S, Nanda A : Long term outcome of Gamma Knife radiosurgery for metastatic brain tumors. J Clin Neurosci 21 : 2122-2128, 2014 https://doi.org/10.1016/j.jocn.2014.05.015
  3. Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC : Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77 : 996-1001, 2010 https://doi.org/10.1016/j.ijrobp.2009.06.006
  4. Fahrig A, Ganslandt O, Lambrecht U, Grabenbauer G, Kleinert G, Sauer R, et al. : Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts. Strahlenther Onkol 183 : 625-630, 2007 https://doi.org/10.1007/s00066-007-1714-1
  5. Feuvret L, Vinchon S, Martin V, Lamproglou I, Halley A, Calugaru V, et al. : Stereotactic radiotherapy for large solitary brain metastases. Cancer Radiother 18 : 97-106, 2014 https://doi.org/10.1016/j.canrad.2013.12.003
  6. Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, et al. : A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28 : 797-802, 1994 https://doi.org/10.1016/0360-3016(94)90098-1
  7. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. : Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 : 745-751, 1997 https://doi.org/10.1016/S0360-3016(96)00619-0
  8. Giubilei C, Ingrosso G, D'Andrea M, Benassi M, Santoni R : Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases. J Neurooncol 91 : 207-212, 2009 https://doi.org/10.1007/s11060-008-9700-8
  9. Higuchi Y, Serizawa T, Nagano O, Matsuda S, Ono J, Sato M, et al. : Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors. Int J Radiat Oncol Biol Phys 74 : 1543-1548, 2009 https://doi.org/10.1016/j.ijrobp.2008.10.035
  10. Jiang XS, Xiao JP, Zhang Y, Xu YJ, Li XP, Chen XJ, et al. : Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters. Radiat Oncol 7 : 36, 2012 https://doi.org/10.1186/1748-717X-7-36
  11. Jo KI, Im YH, Kong DS, Seol HJ, Nam DH, Lee JI : Gamma knife radiosurgery for brain metastases from breast cancer. J Korean Neurosurg Soc 54 : 399-404, 2013 https://doi.org/10.3340/jkns.2013.54.5.399
  12. Kalkanis SN, Kondziolka D, Gaspar LE, Burri SH, Asher AL, Cobbs CS, et al. : The role of surgical resection in the management of newly diagnosed brain metastases : a systematic review and evidence-based clinical practice guideline. J Neurooncol 96 : 33-43, 2010 https://doi.org/10.1007/s11060-009-0061-8
  13. Kim H, Jung TY, Kim IY, Jung S, Moon KS, Park SJ : The usefulness of stereotactic radiosurgery for radioresistant brain metastases. J Korean Neurosurg Soc 54 : 107-111, 2013 https://doi.org/10.3340/jkns.2013.54.2.107
  14. Kim YJ, Cho KH, Kim JY, Lim YK, Min HS, Lee SH, et al. : Single-dose versus fractionated stereotactic radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 81 : 483-489, 2011 https://doi.org/10.1016/j.ijrobp.2010.05.033
  15. Kwon AK, Dibiase SJ, Wang B, Hughes SL, Milcarek B, Zhu Y : Hypofractionated stereotactic radiotherapy for the treatment of brain metastases. Cancer 115 : 890-898, 2009 https://doi.org/10.1002/cncr.24082
  16. Lee CC, Yen CP, Xu Z, Schlesinger D, Sheehan J : Large intracranial metastatic tumors treated by Gamma Knife surgery : outcomes and prognostic factors. J Neurosurg 120 : 52-59, 2014 https://doi.org/10.3171/2013.9.JNS131163
  17. Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, et al. : The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 63 : 37-46, 2005 https://doi.org/10.1016/j.ijrobp.2005.05.023
  18. Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, et al. : Stereotactic radiosurgery for brain metastases : analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6 : 48, 2011 https://doi.org/10.1186/1748-717X-6-48
  19. Minniti G, D'Angelillo RM, Scaringi C, Trodella LE, Clarke E, Matteucci P, et al. : Fractionated stereotactic radiosurgery for patients with brain metastases. J Neurooncol 117 : 295-301, 2014 https://doi.org/10.1007/s11060-014-1388-3
  20. Murai T, Ogino H, Manabe Y, Iwabuchi M, Okumura T, Matsushita Y, et al. : Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases : a dose escalation study. Clin Oncol (R Coll Radiol) 26 : 151-158, 2014 https://doi.org/10.1016/j.clon.2013.11.027
  21. Patchell RA : The management of brain metastases. Cancer Treat Rev 29 : 533-540, 2003 https://doi.org/10.1016/S0305-7372(03)00105-1
  22. Rampling R, Cruickshank G, Lewis AD, Fitzsimmons SA, Workman P : Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 29 : 427-431, 1994 https://doi.org/10.1016/0360-3016(94)90432-4
  23. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, et al. : Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases : final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47 : 291-298, 2000 https://doi.org/10.1016/S0360-3016(99)00507-6
  24. Shehata MK, Young B, Reid B, Patchell RA, St Clair W, Sims J, et al. : Stereotatic radiosurgery of 468 brain metastases < or =2 cm : implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 59 : 87-93, 2004 https://doi.org/10.1016/j.ijrobp.2003.10.009
  25. Shibamoto Y, Yukawa Y, Tsutsui K, Takahashi M, Abe M : Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites. Jpn J Cancer Res 77 : 908-915, 1986
  26. Tome WA : Universal survival curve and single fraction equivalent dose : useful tools in understanding potency of ablative radiotherapy : in regard to Parks et al. (Int J Radiat Oncol Biol Phys 2008;72 : 1620-1621). Int J Radiat Oncol Biol Phys 73 : 1286, 2009
  27. Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH : Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104 : 907-912, 2006 https://doi.org/10.3171/jns.2006.104.6.907
  28. Wegner RE, Leeman JE, Kabolizadeh P, Rwigema JC, Mintz AH, Burton SA, et al. : Fractionated stereotactic radiosurgery for large brain metastases. Am J Clin Oncol 38 : 135-139, 2015 https://doi.org/10.1097/COC.0b013e31828aadac
  29. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. : Updated response assessment criteria for high-grade gliomas : response assessment in neuro-oncology working group. J Clin Oncol 28 : 1963-1972, 2010 https://doi.org/10.1200/JCO.2009.26.3541
  30. Wiggenraad R, Verbeek-de Kanter A, Kal HB, Taphoorn M, Vissers T, Struikmans H : Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol 98 : 292-297, 2011 https://doi.org/10.1016/j.radonc.2011.01.011
  31. Wiggenraad R, Verbeek-de Kanter A, Mast M, Molenaar R, Kal HB, Lycklama a Nijeholt G, et al. : Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases. A single centre study. Strahlenther Onkol 188 : 696-701, 2012 https://doi.org/10.1007/s00066-012-0122-3
  32. Yang HC, Kano H, Lunsford LD, Niranjan A, Flickinger JC, Kondziolka D : What factors predict the response of larger brain metastases to radiosurgery? Neurosurgery 68 : 682-690; discussion 690, 2011 https://doi.org/10.1227/NEU.0b013e318207a58b
  33. Yoo H, Kim YZ, Nam BH, Shin SH, Yang HS, Lee JS, et al. : Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg 110 : 730-736, 2009 https://doi.org/10.3171/2008.8.JNS08448

Cited by

  1. Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer : Evaluation of indications and predictors of local control vol.192, pp.6, 2016, https://doi.org/10.1007/s00066-016-0963-2
  2. Dosimetric effects of a repositioning head frame system and treatment planning system dose calculation accuracy vol.19, pp.6, 2018, https://doi.org/10.1002/acm2.12456
  3. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED10 vol.139, pp.2, 2018, https://doi.org/10.1007/s11060-018-2885-6
  4. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm vol.129, pp.2, 2015, https://doi.org/10.3171/2017.3.jns162532
  5. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm vol.129, pp.2, 2015, https://doi.org/10.3171/2017.3.jns162532
  6. Hypofractionated Radiation Therapy for Large Brain Metastases vol.8, pp.None, 2018, https://doi.org/10.3389/fonc.2018.00379
  7. Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study vol.194, pp.6, 2018, https://doi.org/10.1007/s00066-018-1262-x
  8. Fractionated Stereotactic Radiosurgery for Brain Metastases Using the Novalis Tx® System vol.61, pp.4, 2015, https://doi.org/10.3340/jkns.2018.0002
  9. Cerebral Radiation Necrosis: Incidence, Pathogenesis, Diagnostic Challenges, and Future Opportunities vol.21, pp.8, 2015, https://doi.org/10.1007/s11912-019-0818-y
  10. Fractionated stereotactic radiotherapy for local control of resected brain metastases vol.144, pp.2, 2019, https://doi.org/10.1007/s11060-019-03233-9
  11. Current Treatment of Melanoma Brain Metastasis vol.21, pp.6, 2015, https://doi.org/10.1007/s11864-020-00733-z
  12. A multi-center analysis of single-fraction versus hypofractionated stereotactic radiosurgery for the treatment of brain metastasis vol.15, pp.1, 2020, https://doi.org/10.1186/s13014-020-01522-6
  13. Significant correlation between gross tumor volume (GTV) D98% and local control in multifraction stereotactic radiotherapy (MF-SRT) for unresected brain metastases vol.154, pp.None, 2015, https://doi.org/10.1016/j.radonc.2020.11.021
  14. Hypofractionated frameless gamma knife radiosurgery for large metastatic brain tumors vol.38, pp.1, 2015, https://doi.org/10.1007/s10585-020-10068-6